<DOC>
	<DOCNO>NCT01581528</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood , tissue , bone marrow patient cancer laboratory may help doctor identify learn biomarkers related cancer . It may also help doctor find good way treat cancer . PURPOSE : This research study sample patient T-cell acute lymphoblastic leukemia ( T-ALL ) .</brief_summary>
	<brief_title>Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Determine metabolic status regulation primary T-cell acute lymphoblastic leukemia ( T-ALL ) relative control rest peripheral T cell . - Establish effect metabolic inhibition metabolic stress pathway apoptosis . - Determine metabolic inhibition interacts chemotherapy target therapy drug kill T-ALL cell . OUTLINE : T-ALL sample culture alone gamma secretase inhibitor ( GSI ) PI3K inhibitor analyze metabolic characteristic include glucose transporter 1 ( Glut1 ) expression , mitochondrial mass , phospho-flow 5 ' adenosine monophosphate-activated protein kinase ( AMPK ) , acetyl-CoA carboxylase ( ACC ) , mammalian target rapamycin ( mTOR ) flow cytometry . T-ALL sample normal CD4+ T cell ( control ) also expose ± 2-deoxyglucose ± glutaminolysis inhibitor medium analyze metabolic stress response time particular , AMPK activation , autophagy ( immunofluorescence LC3-II processing ) , BCL2-associated X protein ( Bak ) Bax activation indicate apoptosis . These cell ( T-ALL control ) culture cyclophosphamide , dexamethasone , B-cell CLL/lymphoma 2 ( Bcl-2 ) inhibitor , ABT-737 , determine cell death time .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Sample patient diagnose TALL Samples independent healthy donor obtain Gulf Coast Regional Blood Center ( control ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>T-cell childhood acute lymphoblastic leukemia</keyword>
	<keyword>untreated adult acute lymphoblastic leukemia</keyword>
	<keyword>T-cell adult acute lymphoblastic leukemia</keyword>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
</DOC>